Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
The paper introduces BOAT, a Bayesian optimization framework that uses uncertainty-aware surrogate modeling coupled with a genetic algorithm to jointly optimize multiple predicted antibody properties. BOAT efficiently navigates the high-dimensional antibody sequence space, outperforming genetic algorithms and matching generative learning approaches in multi-objective protein optimization. The study also defines conditions where surrogate-driven optimization is superior to generative methods, highlighting the limitations imposed by sequence dimensionality and oracle costs.
Forget painstakingly filtering antibodies one property at a time – BOAT's multi-objective Bayesian optimization can jointly optimize predicted traits, sometimes even beating expensive generative approaches.
Antibody lead optimization is inherently a multi-objective challenge in drug discovery. Achieving a balance between different drug-like properties is crucial for the development of viable candidates, and this search becomes exponentially challenging as desired properties grow. The ever-growing zoo of sophisticated in silico tools for predicting antibody properties calls for an efficient joint optimization procedure to overcome resource-intensive sequential filtering pipelines. We present BOAT, a versatile Bayesian optimization framework for multi-property antibody engineering. Our `plug-and-play' framework couples uncertainty-aware surrogate modeling with a genetic algorithm to jointly optimize various predicted antibody traits while enabling efficient exploration of sequence space. Through systematic benchmarking against genetic algorithms and newer generative learning approaches, we demonstrate competitive performance with state-of-the-art methods for multi-objective protein optimization. We identify clear regimes where surrogate-driven optimization outperforms expensive generative approaches and establish practical limits imposed by sequence dimensionality and oracle costs.